Question 1

Has Richard Auchus received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,260,939 in general payments to Richard Auchus across 391 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Richard Auchus did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Richard Auchus come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Neurocrine Biosciences, Inc.	148	$834,485
Corcept Therapeutics	183	$275,406
H. Lundbeck A S	17	$45,277
Novartis	2	$42,808
Recordati_rare_diseases_inc.	16	$21,499
Xeris Pharmaceuticals, Inc.	12	$14,642
Besins Healthcare Ireland Limited	4	$10,163
Strongbridge US Inc.	2	$9,126
Novo Nordisk Health Care AG	3	$2,520
Blue Earth Diagnostics	1	$2,250
Roche Diagnostics International Ltd	1	$2,163
Novo Nordisk	1	$563
Eton Pharmaceuticals, Inc.	1	$37

Richard Auchus

Payments from drug & device makers

Who reported the general payments

How this compares

Other endocrinology, diabetes & metabolism in Ann Arbor